+
Site Tour

Dr Ingo Eitel explains why LAAO can be an option in ESKD patients

Dr Ingo Eitel explains why left atrial appendage occlusion can be an option in end stage kidney disease (ESKD) patients 

Related Videos

LAAO Summit - Ideal vs suboptimal LAAO implant

LAAO Summit - LAAO with risk of leak

LAAO Summit - The right antithrombotic regimen

LAAO Summit - Debate: Factor XI inhibitors

LAAO Summit - Mastering leaks

LAAO Summit - Debate: Factor XI inhibitors

LAAO Summit - Decoding DRT patient factors

LAAO Summit - Sealing the appendage

TRENDING TOPICS

CS Webinar-Aortic valvular disease management

TaiIored solutions for lifetime management of aortic valvular heart disease

EuroPCR 25 Symposium: MitraClip and TriClip

Enhancing clipping solutions for durable, long-term patient outcomes

Tendyne patient testimonial: Graham's story

Graham’s 10 years journey with Tendyne™ and Dr. Alison Duncan’s Insight

CONNEXT


HUB
RELATED RESOURCES

The Amulet IDE Trial

Monitoring for AF prior to PFO closure

Amplatzer™ Amulet™ LAA Occluder

CONNEXT


LIVE
RELATED EVENTS

LAAO Summit - Mastering leaks

LAAO Summit - Imaging debate: TEE

LAAO Summit - Sealing the appendage

ESOC 2023: AF patient LAA case

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline